Cortexyme, Inc. (NASDAQ:CRTX)

Cornerstone Therapeutics Inc., incorporated on July 14, 2000, is a specialty pharmaceutical company focused on commercializing products for the hospital, respiratory and related specialty markets. The Company’s promoted products include CUROSURF, ZYFLO CR, FACTIVE and SPECTRACEF. On December 30, 2011, the Company acquired Cardiokine, Inc., a specialty pharmaceutical company, focused on developing hospital products for cardiovascular indications. In March 2012, it acquired the North American product rights for FACTIVE (Gemifloxacin Mesylate) tablets. In June 2012, the Company acquired EKR Therapeutics, Inc.

Web site: http://www.crtx.com

Last updated July 30, 2012


Market Data powered by QuoteMedia. Terms of Use